Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer-Reference-Cited by-同舟云学术

Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

Published:2023-04 Issue:2 Volume:8 Page:101160
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Rudin C.M.,Cervantes A.,Dowlati A.,Besse B.,Ma B.,Costa D.B.,Schmid P.,Heist R.,Villaflor V.M.,Spahn J.,Li S.,Cha E.,Riely G.J.,Gettinger S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha;Am J Cancer Res,2015

3. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update summary;Hanna;J Oncol Pract,2017

4. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2018

5. Checkpoint blockade in lung cancer with driver mutation: choose the road wisely;Calles;Am Soc Clin Oncol Educ Book,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature;Cancer Treatment Reviews;2024-09

2. It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC;Exploration of Targeted Anti-tumor Therapy;2024-07-19

3. Bronchoalveolar lavage fluid metagenomic next-generation sequencing assay for identifying pathogens in lung cancer patients;BIOCELL;2024

4. Cancer cell-intrinsic mechanisms driving acquired immune tolerance;Immunity;2023-10

5. Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review;Cancer Treatment Reviews;2023-09